Analyst Ratings for Arbutus Biopharma (ABUS) [Neutrals]
ABUS Rating Summary
ABUS Price Target Summary
- Highest: $4.00 (JMP Securities)
- Lowest: $4.00 (JMP Securities)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$4.00 (+45.5%)
* Over Last 12-Mos
Rating Score: 7.8 / 10 Percentile Rank: 82%
Rating Score: 7.8 / 10 Percentile Rank: 82%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/24/2020 | Baird | Madhu Kumar | Downgrade | Neutral (Outperform) |
4.00 (N/A) |
2.82 (2.75) |
-2.48% | Details |
8/5/2016 | Leerink Partners » Updated 11/7/2017 |
N/A | Downgrade | Market Perform (Outperform) |
5.50 (4.00) |
4.37 (2.75) |
-37.07% | Details |